In addition to SPP1, GSEA showed that other genes linked to KRAS activation were expressed at higher levels in the brain-derived B16 variants, including the scaffolding protein gene AKAP12 (A-kinase anchoring protein 12), whose increased expression in human metastatic melanomas correlates with reduced survival [20]. Here, KRAS is linked to metastatic melanoma.